624 related articles for article (PubMed ID: 30753422)
21. Angiotensin-(1-7) treatment mitigates right ventricular fibrosis as a distinctive feature of diabetic cardiomyopathy.
Hao PP; Yang JM; Zhang MX; Zhang K; Chen YG; Zhang C; Zhang Y
Am J Physiol Heart Circ Physiol; 2015 May; 308(9):H1007-19. PubMed ID: 25724492
[TBL] [Abstract][Full Text] [Related]
22. Reversal effects of low-dose imatinib compared with sunitinib on monocrotaline-induced pulmonary and right ventricular remodeling in rats.
Leong ZP; Okida A; Higuchi M; Yamano Y; Hikasa Y
Vascul Pharmacol; 2018 Jan; 100():41-50. PubMed ID: 29100963
[TBL] [Abstract][Full Text] [Related]
23. Pioglitazone alleviates cardiac and vascular remodelling and improves survival in monocrotaline induced pulmonary arterial hypertension.
Behringer A; Trappiel M; Berghausen EM; Ten Freyhaus H; Wellnhofer E; Odenthal M; Blaschke F; Er F; Gassanov N; Rosenkranz S; Baldus S; Kappert K; Caglayan E
Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):369-79. PubMed ID: 26742933
[TBL] [Abstract][Full Text] [Related]
24. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
Yang PS; Kim DH; Lee YJ; Lee SE; Kang WJ; Chang HJ; Shin JS
Respir Res; 2014 Nov; 15():148. PubMed ID: 25420924
[TBL] [Abstract][Full Text] [Related]
25. Biventricular structural and functional responses to aortic constriction in a rabbit model of chronic right ventricular pressure overload.
Apitz C; Honjo O; Humpl T; Li J; Assad RS; Cho MY; Hong J; Friedberg MK; Redington AN
J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1494-501. PubMed ID: 22818124
[TBL] [Abstract][Full Text] [Related]
26. Delineating the molecular and histological events that govern right ventricular recovery using a novel mouse model of pulmonary artery de-banding.
Boehm M; Tian X; Mao Y; Ichimura K; Dufva MJ; Ali K; Dannewitz Prosseda S; Shi Y; Kuramoto K; Reddy S; Kheyfets VO; Metzger RJ; Spiekerkoetter E
Cardiovasc Res; 2020 Aug; 116(10):1700-1709. PubMed ID: 31738411
[TBL] [Abstract][Full Text] [Related]
27. Right Ventricular Fibrosis.
Andersen S; Nielsen-Kudsk JE; Vonk Noordegraaf A; de Man FS
Circulation; 2019 Jan; 139(2):269-285. PubMed ID: 30615500
[TBL] [Abstract][Full Text] [Related]
28. Ranolazine prevents INaL enhancement and blunts myocardial remodelling in a model of pulmonary hypertension.
Rocchetti M; Sala L; Rizzetto R; Staszewsky LI; Alemanni M; Zambelli V; Russo I; Barile L; Cornaghi L; Altomare C; Ronchi C; Mostacciuolo G; Lucchetti J; Gobbi M; Latini R; Zaza A
Cardiovasc Res; 2014 Oct; 104(1):37-48. PubMed ID: 25139747
[TBL] [Abstract][Full Text] [Related]
29. The importance of capillary density-stroke work mismatch for right ventricular adaptation to chronic pressure overload.
Noly PE; Haddad F; Arthur-Ataam J; Langer N; Dorfmüller P; Loisel F; Guihaire J; Decante B; Lamrani L; Fadel E; Mercier O
J Thorac Cardiovasc Surg; 2017 Dec; 154(6):2070-2079. PubMed ID: 28712579
[TBL] [Abstract][Full Text] [Related]
30. Increased in vivo mitochondrial oxygenation with right ventricular failure induced by pulmonary arterial hypertension: mitochondrial inhibition as driver of cardiac failure?
Balestra GM; Mik EG; Eerbeek O; Specht PA; van der Laarse WJ; Zuurbier CJ
Respir Res; 2015 Feb; 16(1):6. PubMed ID: 25645252
[TBL] [Abstract][Full Text] [Related]
31. Copaiba Oil Attenuates Right Ventricular Remodeling by Decreasing Myocardial Apoptotic Signaling in Monocrotaline-Induced Rats.
Campos-Carraro C; Turck P; de Lima-Seolin BG; Tavares AMV; Dos Santos Lacerda D; Corssac GB; Teixeira RB; Hickmann A; Llesuy S; da Rosa Araujo AS; Belló-Klein A
J Cardiovasc Pharmacol; 2018 Nov; 72(5):214-221. PubMed ID: 30212415
[TBL] [Abstract][Full Text] [Related]
32. PM2.5 exposure aggravates left heart failure induced pulmonary hypertension.
Chen JJ; Ma WM; Yuan JL; Cui LQ
Acta Cardiol; 2019 Jun; 74(3):238-244. PubMed ID: 30348056
[No Abstract] [Full Text] [Related]
33. Deletion of Fn14 receptor protects from right heart fibrosis and dysfunction.
Novoyatleva T; Schymura Y; Janssen W; Strobl F; Swiercz JM; Patra C; Posern G; Wietelmann A; Zheng TS; Schermuly RT; Engel FB
Basic Res Cardiol; 2013 Mar; 108(2):325. PubMed ID: 23325387
[TBL] [Abstract][Full Text] [Related]
34. Pulmonary vascular mechanical consequences of ischemic heart failure and implications for right ventricular function.
Philip JL; Murphy TM; Schreier DA; Stevens S; Tabima DM; Albrecht M; Frump AL; Hacker TA; Lahm T; Chesler NC
Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1167-H1177. PubMed ID: 30767670
[TBL] [Abstract][Full Text] [Related]
35. Continuous inhalation of carbon monoxide induces right ventricle ischemia and dysfunction in rats with hypoxic pulmonary hypertension.
Gautier M; Antier D; Bonnet P; Le Net JL; Hanton G; Eder V
Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H1046-52. PubMed ID: 17483237
[TBL] [Abstract][Full Text] [Related]
36. Bosentan does not improve pulmonary hypertension and lung remodeling in heart failure.
Jiang BH; Tardif JC; Shi Y; Dupuis J
Eur Respir J; 2011 Mar; 37(3):578-86. PubMed ID: 20595149
[TBL] [Abstract][Full Text] [Related]
37. Comparison of Macitentan and Bosentan on Right Ventricular Remodeling in a Rat Model of Non-vasoreactive Pulmonary Hypertension.
Iglarz M; Landskroner K; Bauer Y; Vercauteren M; Rey M; Renault B; Studer R; Vezzali E; Freti D; Hadana H; Schläpfer M; Cattaneo C; Bortolamiol C; Weber E; Whitby BR; Delahaye S; Wanner D; Steiner P; Nayler O; Hess P; Clozel M
J Cardiovasc Pharmacol; 2015 Nov; 66(5):457-67. PubMed ID: 26230396
[TBL] [Abstract][Full Text] [Related]
38. Cystamine Treatment Fails to Prevent the Development of Pulmonary Hypertension in Chronic Hypoxic Rats.
Markvardsen LK; Sønderskov LD; Wandall-Frostholm C; Pinilla E; Prat-Duran J; Aalling M; Mogensen S; Andersen CU; Simonsen U
J Vasc Res; 2021; 58(4):237-251. PubMed ID: 33910208
[TBL] [Abstract][Full Text] [Related]
39. Rescue treatment with a Rho-kinase inhibitor normalizes right ventricular function and reverses remodeling in juvenile rats with chronic pulmonary hypertension.
Xu EZ; Kantores C; Ivanovska J; Engelberts D; Kavanagh BP; McNamara PJ; Jankov RP
Am J Physiol Heart Circ Physiol; 2010 Dec; 299(6):H1854-64. PubMed ID: 20889845
[TBL] [Abstract][Full Text] [Related]
40. Adverse biventricular remodeling in isolated right ventricular hypertension is mediated by increased transforming growth factor-β1 signaling and is abrogated by angiotensin receptor blockade.
Friedberg MK; Cho MY; Li J; Assad RS; Sun M; Rohailla S; Honjo O; Apitz C; Redington AN
Am J Respir Cell Mol Biol; 2013 Dec; 49(6):1019-28. PubMed ID: 23841477
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
